Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Non-Current Liabilities (2021 - 2024)

Skinvisible's Total Non-Current Liabilities history spans 4 years, with the latest figure at $9.4 million for Q4 2024.

  • On a quarterly basis, Total Non-Current Liabilities rose 2.09% to $9.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was $9.4 million, a 2.09% increase, with the full-year FY2024 number at $9.4 million, up 2.09% from a year prior.
  • Total Non-Current Liabilities hit $9.4 million in Q4 2024 for Skinvisible, down from $10.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for SKVI hit a ceiling of $10.0 million in Q3 2024 and a floor of $5.0 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $7.5 million across 4 years, with a median of $7.6 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 44.2% in 2023 and later rose 2.09% in 2024.
  • Tracing SKVI's Total Non-Current Liabilities over 4 years: stood at $5.6 million in 2021, then increased by 22.8% to $6.9 million in 2022, then skyrocketed by 33.37% to $9.2 million in 2023, then increased by 2.09% to $9.4 million in 2024.
  • Business Quant data shows Total Non-Current Liabilities for SKVI at $9.4 million in Q4 2024, $10.0 million in Q3 2024, and $9.7 million in Q2 2024.